Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 131

1.

Khorasan Disease: Prevalence of HTLV-I Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP) In West Azarbaijan from 2004 to 2007.

Boostani R, Mellat Ardakani A, Ashrafi H.

Iran Red Crescent Med J. 2011 Jun;13(6):428-30. Epub 2011 Jun 1.

2.

Presence of tropical spastic paraparesis/human T-cell lymphotropic virus type 1-associated myelopathy (TSP/HAM)-like among HIV-1-infected patients.

Casseb J, de Oliveira AC, Vergara MP, Montanheiro P, Bonasser F, Meilman Ferreira C, Smid J, Duarte AJ.

J Med Virol. 2008 Mar;80(3):392-8. doi: 10.1002/jmv.21111.

PMID:
18205234
3.

Tropical spastic paraparesis/human T leukemia virus type 1-associated myelopathy in HIV type 1-coinfected patients.

Beilke MA, Japa S, Moeller-Hadi C, Martin-Schild S.

Clin Infect Dis. 2005 Sep 15;41(6):e57-63. Epub 2005 Jul 29.

4.

Levels of serum chemokines discriminate clinical myelopathy associated with human T lymphotropic virus type 1 (HTLV-1)/tropical spastic paraparesis (HAM/TSP) disease from HTLV-1 carrier state.

Guerreiro JB, Santos SB, Morgan DJ, Porto AF, Muniz AL, Ho JL, Teixeira AL Jr, Teixeira MM, Carvalho EM.

Clin Exp Immunol. 2006 Aug;145(2):296-301.

5.

T CD4+ cells count among patients co-infected with human immunodeficiency virus type 1 (HIV-1) and human T-cell leukemia virus type 1 (HTLV-1): high prevalence of tropical spastic paraparesis/HTLV-1-associated myelopathy (TSP/HAM).

Casseb J, Posada-Vergara MP, Montanheiro P, Fukumori LM, Olah I, Smid J, Duarte AJ, Penalva de Oliveira AC.

Rev Inst Med Trop Sao Paulo. 2007 Jul-Aug;49(4):231-3.

6.

Infective dermatitis and human T cell lymphotropic virus type 1-associated myelopathy/tropical spastic paraparesis in childhood and adolescence.

Primo JR, Brites C, Oliveira Mde F, Moreno-Carvalho O, Machado M, Bittencourt AL.

Clin Infect Dis. 2005 Aug 15;41(4):535-41. Epub 2005 Jul 8.

7.

Tropical spastic paraparesis and HTLV-1 associated myelopathy: clinical, epidemiological, virological and therapeutic aspects.

Gessain A, Mahieux R.

Rev Neurol (Paris). 2012 Mar;168(3):257-69. doi: 10.1016/j.neurol.2011.12.006. Epub 2012 Mar 7. Review.

PMID:
22405461
8.
9.

Detection of human T-lymphotropic virus type I p40tax protein in cerebrospinal fluid cells from patients with human T-lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis.

Moritoyo T, Izumo S, Moritoyo H, Tanaka Y, Kiyomatsu Y, Nagai M, Usuku K, Sorimachi M, Osame M.

J Neurovirol. 1999 Jun;5(3):241-8.

PMID:
10414514
10.

Osteoporosis in HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP).

Schachter D, Cartier L, Borzutzky A.

Bone. 2003 Aug;33(2):192-6.

PMID:
14499352
12.

Therapeutic strategies in HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP).

Nakamura T, Nishiura Y, Eguchi K.

Cent Nerv Syst Agents Med Chem. 2009 Jun;9(2):137-49. Review.

PMID:
20021347
13.

Antibody titers to HTLV-I-p40tax protein and gag-env hybrid protein in HTLV-I-associated myelopathy/tropical spastic paraparesis: correlation with increased HTLV-I proviral DNA load.

Kira J, Nakamura M, Sawada T, Koyanagi Y, Ohori N, Itoyama Y, Yamamoto N, Sakaki Y, Goto I.

J Neurol Sci. 1992 Jan;107(1):98-104.

PMID:
1578240
14.

Human T-cell lymphotropic virus type I (HTLV-I) confirmed by PCR-Southern blot and sequencing analysis in a woman with tropical spastic paraparesis.

Perandin F, Cariani A, Bonfanti C, Trainini L, Magoni M, Manca N.

Neurol Sci. 2006 Sep;27(4):257-60.

PMID:
16998729
15.

Risk factors and cofactors for human T-cell lymphotropic virus type I (HTLV-I)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) in Jamaica.

Krämer A, Maloney EM, Morgan OS, Rodgers-Johnson P, Manns A, Murphy EL, Larsen S, Cranston B, Murphy J, Benichou J, et al.

Am J Epidemiol. 1995 Dec 1;142(11):1212-20.

PMID:
7485068
16.

Antibody-dependent cell-mediated cytotoxicity (ADCC) in HTLV-I associated myelopathy/tropical spastic paraparesis (HAM/TSP)

Fujihara K, Itoyama Y, Yu F, Kubo C, Goto I.

J Neurol Sci. 1996 Oct;142(1-2):65-9. Erratum in: J Neurol Sci 1997 Apr 15;147(2):221.

PMID:
8902722
17.

Differentiation of HAM/TSP from patients with multiple sclerosis infected with HTLV-I.

Puccioni-Sohler M, Yamano Y, Rios M, Carvalho SM, Vasconcelos CC, Papais-Alvarenga R, Jacobson S.

Neurology. 2007 Jan 16;68(3):206-13.

PMID:
17224575
18.

Adult T cell leukemia following HTLV-I-associated myelopathy/tropical spastic paraparesis: case reports and implication to the natural course of ATL.

Tamiya S, Matsuoka M, Takemoto S, Shimizu K, Yamaguchi K, Mita S, Uchino M, Ando M, Miyaguni T, Kuniyoshi K, et al.

Leukemia. 1995 Oct;9(10):1768-70.

PMID:
7564523
19.
20.

Survey of the seroprovalence of HTLV I/II in hemodialysis patients and blood donors in Urmia.

Khameneh ZR, Baradaran M, Sepehrvand N.

Saudi J Kidney Dis Transpl. 2008 Sep;19(5):838-41.

Items per page

Supplemental Content

Write to the Help Desk